SAMDaily.us | SNOTE | A | Methylerythritol Pathway (MEP) Pathway Inhibitors

SAMDAILY.US - ISSUE OF APRIL 10, 2022 SAM #7436
SPECIAL NOTICE

A -- Methylerythritol Pathway (MEP) Pathway Inhibitors

Notice Date: 4/8/2022 7:13:48 AM
Notice Type: Special Notice
NAICS: 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
Contracting Office: W4PZ USA MED RSCH ACQUIS ACT FORT DETRICK MD 21702-5014 USA
ZIP Code: 21702-5014
Solicitation Number: JA-22-04-1146
Response Due: 4/23/2022 2:00:00 PM
Point of Contact: Joshua Dean, Phone: 3016192302, Patrick K. Harris
E-Mail Address: joshua.r.dean2.civ@mail.mil, patrick.k.harris11.civ@mail.mil
(joshua.r.dean2.civ@mail.mil, patrick.k.harris11.civ@mail.mil)
Description: The United States Army Medical Research Acquisition Activity (USAMRAA) intends to negotiate on a sole source basis, IAW 10 United States Code 2304(c)(1) as implemented in the Federal Acquisition Regulation 6.302-1(b)(1)(i), to George Washington University (GWU), 805 21ST ST NW STE 301, Washington, District Of Columbia,�20052-0029, as the only responsible source that can provide the Walter Reed Army Institute of Research (WRAIR), Wound Infections Department (WID), Bacterial Disease Branch, technical expertise and support services necessary to synthesize and optimize Methylerythritol Pathway (MEP) inhibitors.
Web Link: SAM.gov Permalink
(https://sam.gov/opp/89d9b6f31fb441848abb274bcc7e82f1/view)
Place of Performance: Address: USA; Country: USA
Record: SN06293171-F 20220410/220408230104 (samdaily.us)
Source: SAM.gov Link to This Notice
(may not be valid after Archive Date)

| FSG Index | This Issue's Index | Today's SAM Daily Index Page |